Cite
HARVARD Citation
Monk, B. et al. (n.d.). O001/#504 Durvalumab, in combination with and following chemoradiotherapy, in locally advanced cervical cancer: results from the phase 3 international, randomized, double-blind, placebo-controlled calla trial. International journal of gynecological cancer. pp. A2-A3. [Online].